TScan Therapeutics Ratios (2020-2025) | TCRX

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter)
-390.33%-374.79%-656.67%-497.55%-534.79%-372.21%-483.05%-604.94%-389.02%-763.82%-591.64%-271.99%-5,325.44%-5,906.90%-2,849.09%-5,220.90%-1,571.95%-1,201.30%-1,422.14%-895.09%
EBIT Margin (Quarter)
-390.63%-374.96%-656.80%-497.62%-535.02%-375.89%-492.95%-602.55%-392.12%-781.77%-636.69%-296.17%-5,542.93%-6,364.55%-3,109.82%-5,520.60%-1,669.74%-1,256.60%-1,475.59%-929.41%
EBITDA Margin (Quarter)
-390.63%-374.96%-656.80%-497.62%-535.02%-375.89%-492.95%-602.55%-392.12%-781.77%-636.69%-296.17%-5,542.93%-6,364.55%-3,109.82%-5,520.60%-1,669.74%-1,256.60%-1,475.59%-929.41%
Operating Margin (Quarter)
-390.63%-374.96%-656.80%-497.62%-535.02%-375.89%-492.95%-602.55%-392.12%-781.77%-636.69%-296.17%-5,542.93%-6,364.55%-3,109.82%-5,520.60%-1,669.74%-1,256.60%-1,475.59%-929.41%
Net Margin (Quarter)
-390.33%-374.79%-656.67%-497.55%-534.79%-372.21%-483.05%-604.94%-389.02%-763.82%-591.64%-271.99%-5,325.44%-5,906.90%-2,849.09%-5,220.90%-1,571.95%-1,201.30%-1,422.14%-895.09%
FCF Margin (Quarter)
-581.85%-552.67%-339.55%-482.87%-679.91%-324.56%-516.24%-513.15%-421.12%-675.70%139.62%-296.63%-5,295.41%-5,053.54%-2,557.77%-4,625.11%-1,746.89%-1,161.87%-1,349.62%-1,253.33%
Efficiency
Assets Average (Quarter)
167.45M196.50M178.16M160.31M158.93M182.27M186.33M245.25M304.15M281.76M256.49M307.85M361.45M359.57M351.91M315.63M280.39M245.51M
Equity Average (Quarter)
-46.19M-54.98M57.02M167.43M153.24M138.67M124.16M108.05M88.73M134.31M179.78M159.91M136.92M189.09M242.15M235.03M225.59M193.46M160.37M133.57M
Invested Capital (Quarter)
-49.92M-60.03M174.07M160.78M145.69M131.65M116.66M99.43M78.02M190.61M170.07M154.21M129.76M265.56M229.09M240.97M210.20M176.71M144.02M123.12M
Asset Utilization Ratio (Quarter)
0.050.050.060.080.080.070.090.060.050.070.060.040.030.010.010.020.030.04
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-82.48-19.13-23.79-25.40-25.20-25.07-32.71-35.83-34.05-46.83-53.39-56.10-53.01-33.99
Debt to Equity (Quarter)
0.250.290.380.160.180.200.250.120.130.130.150.180.230.26
Debt Ratio (Quarter)
0.180.150.170.090.100.110.130.080.090.090.100.110.120.14
Equity Ratio (Quarter)
-0.460.850.850.870.860.710.500.450.600.580.550.510.680.660.650.630.590.550.54
Times Interest Earned (Quarter)
-82.48-19.13-23.79-25.40-25.20-25.07-32.71-35.83-34.05-46.83-53.39-56.10-53.01-33.99
Valuation
Enterprise Value (Quarter)
-121.50M-106.20M-182.31M-161.41M-140.84M-125.60M-137.31M-120.03M-95.61M-208.84M-215.42M-192.04M-162.78M-297.68M-271.12M-290.11M-251.69M-218.04M-184.45M-152.41M
Return Ratios
Return on Sales (Quarter)
-0.04%-0.04%-0.07%-0.05%-0.05%-0.04%-0.05%-0.06%-0.04%-0.08%-0.06%-0.03%-0.53%-0.59%-0.28%-0.52%-0.16%-0.12%-0.14%-0.09%
Return on Capital Employed (Quarter)
-29.24%-27.77%-35.62%-42.93%-43.69%-40.39%-42.50%-39.30%-33.49%-37.09%-45.37%-41.44%-35.90%-41.66%-43.37%-50.73%-59.19%-59.88%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%
Return on Equity (Quarter)
0.01%0.01%-0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%0.00%-0.01%-0.01%-0.01%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%